{"doi":"10.1007\/s00213-004-2058-5","coreId":"135220","oai":"oai:bradscholars.brad.ac.uk:10454\/4046","identifiers":["oai:bradscholars.brad.ac.uk:10454\/4046","10.1007\/s00213-004-2058-5"],"title":"Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.","authors":["Idris, Nagi F.","Repeto, P.","Neill, Joanna C.","Large, C. H."],"enrichments":{"references":[],"documentType":{"type":null}},"contributors":[],"datePublished":"2005","abstract":"noRationale  Phencyclidine (PCP), a glutamate\/N-methyl-d-aspartate (NMDA) receptor antagonist, has been shown to induce a range of symptoms similar to those of patients with schizophrenia, while d-amphetamine induces predominantly positive symptoms. Previous studies in our laboratory have shown that PCP can selectively impair the performance of an operant reversal-learning task in the rat. Furthermore, we found that the novel antipsychotic ziprasidone, but not the classical antipsychotic haloperidol, could prevent the PCP-induced deficit.\\ud\nObjectives  The aim of the present study was to validate the model further using the atypical antipsychotic clozapine and then to investigate the effects of lamotrigine, a broad-spectrum anticonvulsant that is known to reduce glutamate release in vitro and is able to prevent ketamine-induced psychotic symptoms in healthy human volunteers. A further aim was to compare effects of PCP and d-amphetamine in the test and investigate the effects of the typical antipsychotic haloperidol against the latter.\\ud\nMethods  Female hooded-Lister rats were food deprived and trained to respond for food in a reversal-learning paradigm.\\ud\nResults  PCP at 1.5 mg\/kg and 2.0 mg\/kg and d-amphetamine at 0.5 mg\/kg significantly and selectively impaired performance in the reversal phase of the task. The cognitive deficit induced by 1.5 mg\/kg PCP was attenuated by prior administration of lamotrigine (20 mg\/kg and 30 mg\/kg) or clozapine (5 mg\/kg), but not haloperidol (0.05 mg\/kg). In direct contrast, haloperidol (0.05 mg\/kg), but not lamotrigine (25 mg\/kg) or clozapine (5 mg\/kg), prevented a similar cognitive impairment produced by d-amphetamine (0.5 mg\/kg).\\ud\nConclusions  Our findings provide further data to support the use of PCP-induced disruption of reversal learning in rodents to investigate novel antipsychotic drugs. The results also provide evidence for different mechanisms of PCP and d-amphetamine-induced disruption of performance in the test, and their different sensitivities to typical and atypical antipsychotic drugs","downloadUrl":"","fullTextIdentifier":null,"pdfHashValue":null,"publisher":"Springer Berlin \/ Heidelberg","rawRecordXml":"<record><header><identifier>\n        \n            \n                oai:bradscholars.brad.ac.uk:10454\/4046<\/identifier><datestamp>\n                2014-05-19T14:36:41Z<\/datestamp><setSpec>\n                com_10454_152<\/setSpec><setSpec>\n                col_10454_6342<\/setSpec>\n            <\/header><metadata><oai_dc:dc xmlns:oai_dc=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/\" xmlns:dc=\"http:\/\/purl.org\/dc\/elements\/1.1\/\" xmlns:doc=\"http:\/\/www.lyncode.com\/xoai\" xmlns:xsi=\"http:\/\/www.w3.org\/2001\/XMLSchema-instance\" xsi:schemaLocation=\"http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc\/ http:\/\/www.openarchives.org\/OAI\/2.0\/oai_dc.xsd\" ><dc:title>\n            \nInvestigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat.<\/dc:title><dc:creator>\nIdris, Nagi F.<\/dc:creator><dc:creator>\nRepeto, P.<\/dc:creator><dc:creator>\nNeill, Joanna C.<\/dc:creator><dc:creator>\nLarge, C. H.<\/dc:creator><dc:subject>\nPhencyclidine<\/dc:subject><dc:subject>\nd-Amphetamine<\/dc:subject><dc:subject>\nReversal learning<\/dc:subject><dc:subject>\nCognitive deficit<\/dc:subject><dc:subject>\nSchizophrenia<\/dc:subject><dc:subject>\nLamotrigine<\/dc:subject><dc:subject>\nClozapine<\/dc:subject><dc:subject>\nHaloperidol<\/dc:subject><dc:subject>\nAntipsychotics<\/dc:subject><dc:description>\nno<\/dc:description><dc:description>\nRationale  Phencyclidine (PCP), a glutamate\/N-methyl-d-aspartate (NMDA) receptor antagonist, has been shown to induce a range of symptoms similar to those of patients with schizophrenia, while d-amphetamine induces predominantly positive symptoms. Previous studies in our laboratory have shown that PCP can selectively impair the performance of an operant reversal-learning task in the rat. Furthermore, we found that the novel antipsychotic ziprasidone, but not the classical antipsychotic haloperidol, could prevent the PCP-induced deficit.\\ud\nObjectives  The aim of the present study was to validate the model further using the atypical antipsychotic clozapine and then to investigate the effects of lamotrigine, a broad-spectrum anticonvulsant that is known to reduce glutamate release in vitro and is able to prevent ketamine-induced psychotic symptoms in healthy human volunteers. A further aim was to compare effects of PCP and d-amphetamine in the test and investigate the effects of the typical antipsychotic haloperidol against the latter.\\ud\nMethods  Female hooded-Lister rats were food deprived and trained to respond for food in a reversal-learning paradigm.\\ud\nResults  PCP at 1.5 mg\/kg and 2.0 mg\/kg and d-amphetamine at 0.5 mg\/kg significantly and selectively impaired performance in the reversal phase of the task. The cognitive deficit induced by 1.5 mg\/kg PCP was attenuated by prior administration of lamotrigine (20 mg\/kg and 30 mg\/kg) or clozapine (5 mg\/kg), but not haloperidol (0.05 mg\/kg). In direct contrast, haloperidol (0.05 mg\/kg), but not lamotrigine (25 mg\/kg) or clozapine (5 mg\/kg), prevented a similar cognitive impairment produced by d-amphetamine (0.5 mg\/kg).\\ud\nConclusions  Our findings provide further data to support the use of PCP-induced disruption of reversal learning in rodents to investigate novel antipsychotic drugs. The results also provide evidence for different mechanisms of PCP and d-amphetamine-induced disruption of performance in the test, and their different sensitivities to typical and atypical antipsychotic drugs.<\/dc:description><dc:date>\n2009-12-10T15:49:13Z<\/dc:date><dc:date>\n2009-12-10T15:49:13Z<\/dc:date><dc:date>\n2005<\/dc:date><dc:type>\nArticle<\/dc:type><dc:type>\npublished version paper<\/dc:type><dc:identifier>\nIdris, N. F., Repeto, P., Neill, J. C. and  Large, C. H. (2005). Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and D-amphetamine in the rat. Psychopharmacology, Vol. 179, No. 2, pp.336-348.<\/dc:identifier><dc:identifier>\n900124871<\/dc:identifier><dc:identifier>\n900043340<\/dc:identifier><dc:identifier>\nhttp:\/\/hdl.handle.net\/10454\/4046<\/dc:identifier><dc:language>\nen<\/dc:language><dc:relation>\nhttp:\/\/dx.doi.org\/10.1007\/s00213-004-2058-5<\/dc:relation><dc:publisher>\nSpringer Berlin \/ Heidelberg<\/dc:publisher>\n<\/oai_dc:dc>\n<\/metadata>\n        <\/record>","journals":null,"language":null,"relations":["http:\/\/dx.doi.org\/10.1007\/s00213-004-2058-5"],"year":2005,"topics":["Phencyclidine","d-Amphetamine","Reversal learning","Cognitive deficit","Schizophrenia","Lamotrigine","Clozapine","Haloperidol","Antipsychotics"],"subject":["Article","published version paper"],"fullText":null}